Navigation Links
Clarient Reports 2009 Third Quarter; Nine Month Results
Date:11/3/2009

a clearer picture of receivables, and help to improve future collections. And finally it will allow us to better forecast our future revenues, bad debts, profits and cash flows."

Land continued, "Taking into account these new estimates, we are now revising our revenue guidance for 2009 to $90 million to $94 million from the previous range of $96 million to $101 million. Even at the low end of the range, this will represent a year-over-year growth rate of greater than 22 percent from our 2008 revenues of $73.7 million."

Andrews concluded, "Clarient's business model built on a balanced revenue stream across multiple cancer types and technologies is well-positioned in the new environment of health reform and cost containment. The opportunities for Clarient to use its established commercial engine to bring new advanced tests to market are numerous and growing daily, and the greater predictability we now have will allow us to assertively pursue some exciting new opportunities while maintaining a focus on profitability and cash flow."

Conference Call

Clarient will hold a conference call to discuss third quarter 2009 results. The call will include a period for questions and answers.

Date: Tuesday, November 3, 2009

Time: 5:00 p.m. Eastern

Call-in Number: 1-888-549-7704 (domestic) 1-480-629-9857 (international)

Conference ID Number: 4177526

Webcast: www.clarientinc.com/investor

Web Replay: For those unable to participate during the live broadcast, a replay of the webcast will be archived at www.clarientinc.com/investor shortly after the call and will be available for one year.

About Clarient

Clarient combines innovative diagnostic technologies w
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Clarient to Present at Noble Financials 5th Annual Equity Conference on Tuesday, June 9th
2. Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
3. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
4. Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
5. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
6. Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer
7. Jim Agnello to Resign as Clarient Chief Financial Officer
8. Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
9. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
10. Clarient to Commercialize Novel Breast Cancer Profile
11. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Ambassador to Speak at Economic Club of Cana...us) November 25, 2009 -- Ambassador to Speak at Ec... French Ambassador for International Investment, a... ,To view a biography of David Appia go to www.in...s available to meet with press to discuss recent p...
(Date:11/25/2009)... ON, Nov. 25 /PRNewswire/ - Cytochroma today annou...ard of Directors. Dr. Moldt will replace Mr. Ulrik...ny,s Board. The number of Board members remains un... to welcome Peter Moldt to the board and look forw... as Cytochroma continues to make progress in becom...
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Brazil Bioethanol M...//www.reportlinker.com/p0165503/Brazil-Bioethanol-...Brazil Bioethanol Market Analysis and Forecasts to...tailed analysis and forecasts of the global bioeth...
(Date:11/24/2009)...vailable in German . , Whether it,s CD pack...gs (Radio Frequency Identification) are increasing... it possible to label objects or goods and identif...priate scanner can read and process the data conta...goods under production conditions of up to 100 deg...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2
...BANE, Calif., Sept. 18 InterMune, Inc.,(Nasdaq: ...ject to market,and other conditions, 3,000,000 sha...offering. The Company expects to grant the underwr...nal 450,000 shares of common,stock in connection w...g,will be sold by InterMune. Goldman, Sachs & Co....
...URY, Conn., Sept. 18 /PRNewswire-FirstCall/-- Biod...clinical data from its VIAject(TM) program,at the ...on for the Study,of Diabetes (EASD). VIAject(TM) ...presentation at EASD entitled, "Pharmacokinetics a...n lispro and regular human insulin when injected,s...
...a-Fine Beam Shaping Device Optimized for Targeting...tereotactic Radiotherapy and Radiosurgery, PALO A.... (NYSE: VAR ) has received FDA 510(k) clearance ...C), an ultra-fine beam shaping,device for radiosur...les clinicians to deliver,extremely precise radios...
Other Biology Technology:InterMune Announces Proposed Public Offering of Common Stock 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 3Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 2Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 3
(Date:11/24/2009)...rstanding how sounds associated with Navy sonar mi...hey hear it at all. , The same type of large ind...ect flaws in the space shuttle,s behemoth solid fu...de the giant head of a whale. The scans are provid...,s hearing anatomy using a breakthrough method dev...
(Date:11/24/2009)...es from collapsing have been true life-savers. But...ed -- once the arteries are strengthened, they bec... but to leave them in place. , Prof. Meital Zilb...dical Engineering has developed a new patent-pendi... needed, then dissolves. , "Our new composite fi...
(Date:11/24/2009)...l Toxicology (ACMT) have signed an agreement to co...dical Toxicology (JMT), the official journal of t...ly published by the University of Pennsylvania Pre...nternational, peer-reviewed journal, is dedicated ...oxicology. The quarterly journal focuses on the d...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2Cost effectiveness of blood pressure device evaluated 59562 1Cost effectiveness of blood pressure device evaluated 59562 2Cost effectiveness of blood pressure device evaluated 59562 3Concordia University to construct new building for genomics research 10381 1Concordia University to construct new building for genomics research 10381 2Concordia University to construct new building for genomics research 10381 3Concordia University to construct new building for genomics research 10381 4Concordia University to construct new building for genomics research 10381 5Concordia University to construct new building for genomics research 10381 6Smoking Bans Good for Non Smokers Hearts 3A Study 59559 1Smoking Bans Good for Non Smokers Hearts 3A Study 59559 2Smoking Bans Good for Non Smokers Hearts 3A Study 59559 3
...be held at the University of Edinburgh, 3-6 Septem...uids, fingers, faeces and flies: food and waterbor...ations. , Hepatitis E virus (HEV), which can be f...nd developing countries but scientists in the Neth...es are contracting the virus from pork. It is one ...
...n levels in coastal waters interfere with fish rep...ine scientist from The University of Texas at Aust...s of seasonal low levels of oxygen, known as hypox...throughout the world over the past few decades, la...agricultural and industrial activities. Hypoxias l...
...eased stress could indicate that pregnancy-induced... found Temple University researcher Kathleen Black...r/October issue of the Journal of Obstetric, Gynec...ariable and can change quickly. We need to be awar...r number of symptoms could also mean [pregnancy-in...
Other Biology News:Society for General Microbiology 161st Meeting, University of Edinburgh 2Low oxygen in coastal waters impairs fish reproduction 2Study identifies warning signs of pregnancy danger 2Study identifies warning signs of pregnancy danger 3
MasterAmp 2X PCR PreMix F without (NH4)2SO4 from EPICENTRE Biotechnologies
HRP Protein Marker Detection Pack from New England Biolabs
Rabbit Anti-Human JMJD2B Polyclonal Antibody, Unconjugated from ProSci, Inc
Agarose from BioPioneer
Biology Products: